Security record · archived quarter
CPRX
Catalyst Pharmaceuticals, Inc. · Healthcare · Biotechnology
10Tracked holders
—Δ holders
9.29MShares held
$143.84MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 109 | -4 | 77.02M | $2.42B | +12 | −16 |
| Q1 2026 | 116 | +4 | 78.68M | $1.95B | +8 | −4 |
| Q4 2025 | 111 | 0 | 78.17M | $1.82B | — | — |
| Q3 2025 | 19 | 0 | 48.11M | $947.78M | — | −1 |
| Q2 2025 | 17 | +1 | 43.29M | $939.35M | +1 | — |
| Q1 2025 | 13 | -1 | 14.99M | $363.56M | — | −1 |
| Q4 2024 | 14 | 0 | 15.06M | $314.25M | +1 | −1 |
| Q3 2024 | 13 | +3 | 9.07M | $180.23M | +4 | −1 |
| Q2 2024 | 10 | — | 9.29M | $143.84M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 2.70M | — | $41.81M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 2.70M | — | $41.81M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Renaissance Technologies ✦ | 2.18M | — | $33.70M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.23M | — | $19.10M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 1.23M | — | $19.10M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Marshall Wace ✦ | 1.22M | — | $18.89M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Point72 Asset Management ✦ | 618.30K | — | $9.58M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 582.92K | — | $9.03M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 488.39K | — | $7.57M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 488.39K | — | $7.57M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 488.39K | — | $7.57M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Millennium Management ✦ | 129.81K | — | $2.01M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Fisher Asset Management ✦ | 105.53K | — | $1.63M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Gotham Asset Management ✦ | 33.70K | — | $521,967 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 378 holders, 103.75M shares, $2.50B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API